Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis | 6 | 2022 | 1129 | 2.100 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 7 | 2016 | 374 | 1.100 |
Why?
|
Gastritis | 2 | 2022 | 185 | 1.020 |
Why?
|
Hepatitis | 2 | 2021 | 213 | 0.920 |
Why?
|
Enterocolitis | 1 | 2022 | 93 | 0.870 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2021 | 394 | 0.850 |
Why?
|
Gastrointestinal Tract | 2 | 2018 | 825 | 0.800 |
Why?
|
Methylprednisolone | 1 | 2021 | 400 | 0.770 |
Why?
|
DNA Glycosylases | 3 | 2020 | 135 | 0.740 |
Why?
|
Colitis, Microscopic | 1 | 2020 | 68 | 0.730 |
Why?
|
Colitis, Lymphocytic | 1 | 2019 | 21 | 0.730 |
Why?
|
Alanine Transaminase | 1 | 2021 | 599 | 0.720 |
Why?
|
Gastroparesis | 1 | 2020 | 123 | 0.700 |
Why?
|
Melanoma | 3 | 2020 | 5274 | 0.650 |
Why?
|
Immunotherapy | 5 | 2022 | 4118 | 0.610 |
Why?
|
Education, Medical, Continuing | 1 | 2022 | 872 | 0.610 |
Why?
|
Mucous Membrane | 1 | 2019 | 669 | 0.550 |
Why?
|
Adenomatous Polyposis Coli | 3 | 2015 | 214 | 0.530 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1155 | 0.450 |
Why?
|
Intestinal Neoplasms | 2 | 2012 | 297 | 0.440 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2012 | 176 | 0.430 |
Why?
|
Neoplasms | 6 | 2022 | 20515 | 0.380 |
Why?
|
Gastroenterology | 1 | 2016 | 514 | 0.380 |
Why?
|
Genetic Testing | 5 | 2020 | 3319 | 0.380 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 820 | 0.370 |
Why?
|
Paracentesis | 1 | 2009 | 94 | 0.360 |
Why?
|
Diarrhea | 3 | 2022 | 1369 | 0.350 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 11284 | 0.350 |
Why?
|
Colorectal Neoplasms | 5 | 2020 | 6575 | 0.340 |
Why?
|
Dysentery | 1 | 2007 | 13 | 0.330 |
Why?
|
Adenoma | 2 | 2020 | 2113 | 0.310 |
Why?
|
Vitamin D | 1 | 2020 | 3163 | 0.290 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2861 | 0.290 |
Why?
|
Pancreatic Neoplasms | 2 | 2016 | 5000 | 0.290 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2272 | 0.290 |
Why?
|
Early Detection of Cancer | 3 | 2016 | 2930 | 0.280 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 362 | 0.280 |
Why?
|
Intestine, Small | 1 | 2012 | 1230 | 0.280 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2012 | 681 | 0.280 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2007 | 263 | 0.270 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 511 | 0.260 |
Why?
|
Carcinoma | 1 | 2016 | 2325 | 0.260 |
Why?
|
Medical Oncology | 1 | 2016 | 2114 | 0.250 |
Why?
|
Peutz-Jeghers Syndrome | 2 | 2016 | 47 | 0.250 |
Why?
|
Liver | 1 | 2018 | 7647 | 0.220 |
Why?
|
Internal Medicine | 1 | 2009 | 1006 | 0.220 |
Why?
|
Glucocorticoids | 2 | 2022 | 2109 | 0.220 |
Why?
|
Lymphadenitis | 1 | 2022 | 101 | 0.220 |
Why?
|
Educational Measurement | 1 | 2009 | 1279 | 0.220 |
Why?
|
Pancreatitis, Chronic | 2 | 2016 | 266 | 0.200 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2020 | 80 | 0.200 |
Why?
|
Medical History Taking | 1 | 2004 | 801 | 0.200 |
Why?
|
Liver Function Tests | 1 | 2021 | 537 | 0.190 |
Why?
|
Genes, APC | 1 | 2020 | 160 | 0.190 |
Why?
|
Immune System Diseases | 1 | 2022 | 266 | 0.190 |
Why?
|
Retrospective Studies | 7 | 2022 | 72253 | 0.180 |
Why?
|
Middle Aged | 17 | 2022 | 214868 | 0.180 |
Why?
|
Jews | 1 | 2020 | 371 | 0.170 |
Why?
|
Humans | 32 | 2022 | 715118 | 0.170 |
Why?
|
Gastric Emptying | 1 | 2020 | 233 | 0.170 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6371 | 0.170 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1730 | 0.160 |
Why?
|
Education, Medical, Graduate | 1 | 2009 | 2205 | 0.150 |
Why?
|
Radionuclide Imaging | 1 | 2020 | 2034 | 0.150 |
Why?
|
Abdominal Pain | 1 | 2022 | 1028 | 0.140 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2016 | 94 | 0.140 |
Why?
|
Drug Resistance | 1 | 2021 | 1612 | 0.140 |
Why?
|
Female | 19 | 2021 | 377328 | 0.140 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2016 | 3555 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 3950 | 0.130 |
Why?
|
Feces | 1 | 2020 | 1382 | 0.130 |
Why?
|
Adult | 12 | 2022 | 212128 | 0.120 |
Why?
|
Genetic Counseling | 2 | 2009 | 582 | 0.120 |
Why?
|
Clinical Competence | 1 | 2009 | 4646 | 0.120 |
Why?
|
Male | 16 | 2021 | 351080 | 0.120 |
Why?
|
Aged | 10 | 2021 | 162672 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1847 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8671 | 0.110 |
Why?
|
Endosonography | 1 | 2016 | 575 | 0.110 |
Why?
|
Lymphocytes | 1 | 2020 | 2748 | 0.110 |
Why?
|
Pancreatitis | 1 | 2018 | 1064 | 0.100 |
Why?
|
Mutation | 2 | 2015 | 29441 | 0.100 |
Why?
|
Risk Assessment | 4 | 2021 | 23510 | 0.100 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2010 | 61 | 0.100 |
Why?
|
Colonic Neoplasms | 1 | 2022 | 2530 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1838 | 0.100 |
Why?
|
Liver Diseases | 1 | 2018 | 1254 | 0.090 |
Why?
|
Internship and Residency | 1 | 2009 | 5618 | 0.090 |
Why?
|
Anti-Bacterial Agents | 1 | 2007 | 7045 | 0.090 |
Why?
|
Pedigree | 2 | 2009 | 4722 | 0.090 |
Why?
|
Phenotype | 3 | 2020 | 16373 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2020 | 2794 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8734 | 0.080 |
Why?
|
Neutrophils | 1 | 2020 | 3850 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58503 | 0.070 |
Why?
|
DNA Mismatch Repair | 1 | 2009 | 410 | 0.070 |
Why?
|
Intestinal Fistula | 1 | 2007 | 151 | 0.070 |
Why?
|
Benzamides | 1 | 2012 | 1411 | 0.070 |
Why?
|
Disease Progression | 1 | 2022 | 13302 | 0.070 |
Why?
|
Prevalence | 2 | 2021 | 14869 | 0.070 |
Why?
|
Survivors | 1 | 2016 | 2165 | 0.070 |
Why?
|
Colonic Diseases | 1 | 2007 | 209 | 0.070 |
Why?
|
Pyrroles | 1 | 2012 | 1187 | 0.070 |
Why?
|
Prognosis | 2 | 2019 | 29167 | 0.070 |
Why?
|
Colonoscopy | 2 | 2010 | 1316 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2015 | 23281 | 0.060 |
Why?
|
Logistic Models | 3 | 2010 | 13594 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2020 | 4230 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2936 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1860 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4311 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9772 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9584 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 16011 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 4924 | 0.060 |
Why?
|
Hospitalization | 1 | 2021 | 9718 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2540 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2012 | 2567 | 0.050 |
Why?
|
Mass Screening | 2 | 2010 | 5204 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13731 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9022 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4910 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 5098 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2007 | 1509 | 0.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 931 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6531 | 0.050 |
Why?
|
Pyrimidines | 1 | 2012 | 2969 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11317 | 0.050 |
Why?
|
Drug Resistance, Bacterial | 1 | 2007 | 1093 | 0.050 |
Why?
|
Adolescent | 3 | 2021 | 85001 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2020 | 12566 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4320 | 0.040 |
Why?
|
Quality of Life | 1 | 2016 | 11691 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 17395 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 56155 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 62186 | 0.030 |
Why?
|
Triage | 1 | 2020 | 928 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3713 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 13267 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15258 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2004 | 3463 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2009 | 19497 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7480 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12477 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6750 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.020 |
Why?
|
Heterozygote | 1 | 2015 | 2791 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9968 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7226 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5333 | 0.020 |
Why?
|
Risk Factors | 2 | 2010 | 70705 | 0.020 |
Why?
|
Alleles | 1 | 2015 | 7095 | 0.010 |
Why?
|
Population Surveillance | 1 | 2010 | 2631 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2753 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 39804 | 0.010 |
Why?
|
United States | 1 | 2010 | 67666 | 0.000 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_